Evidence map›Paper›PMID 35718758›Full record

ArticleJournal of cachexia, sarcopenia and muscle2022

Eggshell membrane modulates gut microbiota to prevent murine pre-cachexia through suppression of T helper cell differentiation.

Huijuan Jia, Weida Lyu, Kazuki Hirota, Eri Saito, Moe Miyoshi, Hirohiko Hohjoh, Kyohei Furukawa, Kenji Saito, Makoto Haritani, Akashi Taguchi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Cancer cachexia: molecular basis and therapeutic advances.Signal transduction and targeted therapy · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. The Loss of YTHDC1 in Gut Macrophages Exacerbates Inflammatory Bowel Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Huijuan JiaHealth Nutrition, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan.
Weida LyuHealth Nutrition, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan.
Kazuki HirotaHealth Nutrition, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan.
Eri SaitoHealth Nutrition, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan.
Moe MiyoshiHealth Nutrition, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan.
Hirohiko HohjohNational Institute of Neuroscience, NCNP, Tokyo, Japan.
Kyohei FurukawaHealth Nutrition, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan.
Kenji SaitoHealth Nutrition, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan.
Makoto HaritaniEnvironmental Science for Sustainable Development Graduate School of Agriculture and Life Sciences, University of Tokyo, Tokyo, Japan.
Akashi TaguchiResearch Center for Advanced Science and Technology, University of Tokyo, Tokyo, Japan.
Yukio HasebeALMADO Inc., Tokyo, Japan.
Hisanori KatoHealth Nutrition, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan.ORCID 0000-0001-9140-7698
University of Tokyo Health Sciences · JPNational Center of Neurology and Psychiatry · JPPromotion and Mutual Aid Corporation for Private Schools of Japan · JPThe University of Tokyo · JPTokyo University of Science · JP

Funding

Japan Society for the Promotion of Science (JSPS) 18K11095
6 · The paper itself

Abstract

backgroundCachexia is a life-threatening condition observed in several pathologies, such as cancer or chronic diseases. Interleukin 10 (Il10) gene transfer is known to improve cachexia by downregulating Il6. Here, we used an IL10-knockout mouse model to simulate cachexia and investigate the effects of eggshell membrane (ESM), a resistant protein, on general pre-cachexia symptoms, which is particularly important for the development of cachexia therapeutics.

methodsFive-week-old male C57BL6/J mice were fed an AIN-93G powdered diet (WT), and 5-week-old male B6.129P2-Il10 < tm1Cgn>/J (IL10

resultsThe body weight, weight of gastrocnemius muscle and fat tissues, colon weight/length ratio, plasma HDL and NEFA, muscular PECAM-1 levels (P < 0.01), plasma glucose and colonic mucosal myeloperoxidase activity (P < 0.05) and T helper (Th) 17 cell abundance (P = 0.071) were improved in KOE mice over KO mice. Proteomic analysis indicated the protective role of ESM in muscle weakness and maintenance of muscle formation (>1.5-fold). Transcriptomic analysis revealed that ESM supplementation suppressed the LPS/IL1-mediated inhibition of RXR function pathway in the liver and downregulated the colonic mucosal expression of chemokines and Th cell differentiation-related markers (P < 0.01) by suppressing the upstream BATF pathway. Analysis of the intestinal microenvironment revealed that ESM supplementation ameliorated the microbial alpha diversity and the abundance of microbiota associated with the degree of inflammation (P < 0.05) and increased the level of total organic acids, particularly of SCFAs such as butyrate (2.3-fold), which could inhibit Th1 and Th17 production.

conclusionsESM supplementation ameliorated the chief symptoms of cachexia, including anorexia, lean fat tissue mass, skeletal muscle wasting and reduced physical function. ESM also improved colon and skeletal muscle inflammation, lipid metabolism and microbial dysbiosis. These results along with the suppressed differentiation of Th cells could be associated with the beneficial intestinal microenvironment and, subsequently, attenuation of pre-cachexia. Our findings provide insights into the potential of ESM in complementary interventions for pre-cachexia prevention.

Indexed as

CachexiaEgg ShellGastrointestinal MicrobiomeT-Lymphocytes, Helper-InducerAnimalsCell DifferentiationDietInflammationInterleukin-10MaleMiceMice, Inbred C57BLProteomicsInterleukin-10CachexiaEgg shell membraneGut microbiotaIL10-knockout miceSCFAT helper cells differentiation

Identifiers

PMID35718758
PMCPMC9397561
OpenAlexW4283163404

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.